Skip to main navigation Skip to search Skip to main content

Retraction: Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up (Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (2021) 40 4 (152-157))

  • Amir Dori
  • , Michela Guglieri
  • , Marianna Scutifero
  • , Luigia Passamano
  • , Antonio Trabacca
  • , Luisa Politano

    Research output: Contribution to journal › Comment/debate

    Abstract

    [This retracts the article DOI: 10.36185/2532-1900-058.].

    Original languageEnglish
    Pages (from-to)101
    Number of pages1
    JournalActa Myologica
    Volume41
    Issue number2
    StatePublished - 1 Jun 2022

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Retraction: Can symptomatic nmDuchenne carriers benefit from treatment with ataluren? Results of 193-month follow-up (Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology (2021) 40 4 (152-157))'. Together they form a unique fingerprint.

    Cite this